Abbvie Inc
Change company Symbol lookup
Select an option...
ABBV Abbvie Inc
AXS AXIS Capital Holdings Ltd
SPNS Sapiens International Corporation NV
SPCE Virgin Galactic Holdings Inc
BBLG Bone Biologics Corp
RPT RPT Realty
CLM Cornerstone Strategic Value Fund
RCI Rogers Communications Inc
ADRA Adara Acquisition Corp
EVTC Evertec Inc
Go

Health Care : Biotechnology | Large Cap Value

AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products include Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.

Closing Price: $140.25

Day's Change: -0.09 (-0.06%)

Bid: --

Ask: --

B/A Size: --

Day's High: 142.24

Day's Low: 139.88

Volume (Light) Volume: 3,819,828 10-day average volume: 6,683,311: 3,819,828

Today's News, August 09, 2022
4:33 pm ET	AbbVie Inc. Stock Falls Tuesday, Still Outperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) sank 0.06% to $140.25 Tuesday, on what proved to be an all-around rough trading session for the stock market...(MarketWatch)
Yesterday's News, August 08, 2022
4:33 pm ET	AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) rallied 1.67% to $140.34 Monday, on what proved to be an all-around mixed trading session for the stock market...(MarketWatch)
August 06, 2022
10:17 am ET	Pharmaceutical CEOs use earnings calls to criticize drug-pricing proposal Jaimy Lee Executives at AbbVie, J&J, and Merck took aim at new drug-pricing proposals that would allow the government to negotiate prices for some medications (MarketWatch)
August 05, 2022
4:33 pm ET	AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) slumped 0.63% to $138.04 Friday, on what proved to be an all-around mixed trading session for the stock market...(MarketWatch)
August 04, 2022
4:33 pm ET	AbbVie Inc. Stock Underperforms Thursday When Compared To Competitors This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. (ABBV) slipped 1.61% to $138.92 Thursday, on what proved to be an all-around poor trading session for the stock market...(MarketWatch)
August 03, 2022
4:33 pm ET	AbbVie Inc. Stock Rises Wednesday, Still Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV inched 0.58% higher to $141.20 Wednesday, on what proved to be an all-around positive trading session for the...(MarketWatch)
August 02, 2022
4:33 pm ET	AbbVie Inc. Stock Outperforms Market On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV inched 0.12% higher to $140.39 Tuesday, on what proved to be an all-around dismal trading session for the stock...(MarketWatch)
August 01, 2022
4:33 pm ET	AbbVie Inc. Stock Falls Monday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV shed 2.29% to $140.22 Monday, on what proved to be an all-around rough trading session for the stock market, with...(MarketWatch)
July 29, 2022
4:33 pm ET	AbbVie Inc. Stock Falls Friday, Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV shed 4.17% to $143.51 Friday, on what proved to be an all-around favorable trading session for the stock market...(MarketWatch)
8:17 am ET	AbbVie reports an increase in second-quarter revenue, led by sales of Humira Shares of AbbVie Inc. (ABBV) were down 1.3% in premarket trading on Friday though the company met earnings and revenue expectations for the second quarter of the year. AbbVie had earnings of $924 million, or 51 cents per share, in the second...(MarketWatch)
7:46 am ET	AbbVie Q2 Botox Cosmetic revenue up 18.9% to $695 mln; FactSet consensus $664.3 mln (END) Dow Jones Newswires July 29, 2022 07:46 ET (11:46 GMT) (MarketWatch)
7:45 am ET	AbbVie Q2 Immunology revenue up 17.8% to $7.21 bln; FactSet consensus $6.86 bln (END) Dow Jones Newswires July 29, 2022 07:45 ET (11:45 GMT) (MarketWatch)
7:44 am ET	AbbVie affirms 2022 adj. EPS outlook $13.78-$13.98; FactSet consensus $13.89 (END) Dow Jones Newswires July 29, 2022 07:44 ET (11:44 GMT) (MarketWatch)
7:43 am ET	AbbVie Q2 EPS 51 cents vs. 42 cents a year ago (END) Dow Jones Newswires July 29, 2022 07:43 ET (11:43 GMT) (MarketWatch)
7:43 am ET	AbbVie Q2 adj. EPS $3.37; FactSet consensus $3.32 (END) Dow Jones Newswires July 29, 2022 07:43 ET (11:43 GMT) (MarketWatch)
7:43 am ET	AbbVie Q2 revenue $14.58 bln vs. $13.96 bln a year ago; FactSet consensus $14.67 bln (END) Dow Jones Newswires July 29, 2022 07:43 ET (11:43 GMT) (MarketWatch)
July 28, 2022
4:33 pm ET	AbbVie Inc. Stock Outperforms Competitors Despite Losses On The Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV slipped 0.93% to $149.75 Thursday, on what proved to be an all-around positive trading session for the stock...(MarketWatch)
July 27, 2022
4:33 pm ET	AbbVie Inc. Stock Rises Wednesday, Still Underperforms Market This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV inched 0.19% higher to $151.15 Wednesday, on what proved to be an all-around positive trading session for the...(MarketWatch)
July 26, 2022
4:33 pm ET	AbbVie Inc. Stock Underperforms Tuesday When Compared To Competitors Despite Daily Gains This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV inched 0.43% higher to $150.87 Tuesday, on what proved to be an all-around grim trading session for the stock...(MarketWatch)
July 25, 2022
4:33 pm ET	AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of AbbVie Inc. ABBV rose 1.18% to $150.22 Monday, on what proved to be an all-around positive trading session for the stock market...(MarketWatch)
Next >

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for varies.

Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and